BPTH Stock Price, Bio-Path Holdings Inc Quote, Chart

Market Summary

USD2.14-0.20

Market Closed

-8.55%

BPTH Stock Price

View Fullscreen

BPTH RSI Chart

BPTH Valuation

Market Cap

3.5M

Price/Earnings (Trailing)

-0.25

EV/EBITDA

-0.75

Price/Free Cashflow

-0.4

MarketCap/EBT

-0.77

BPTH Price/Sales (Trailing)

BPTH Profitability

Return on Equity

531.89%

Return on Assets

-789.71%

Free Cashflow Yield

-251.67%

BPTH Fundamentals

BPTH Earnings

Earnings (TTM)

-14.0M

Earnings Growth (Yr)

40.13%

Earnings Growth (Qtr)

6.38%

Breaking Down BPTH Revenue

Last 7 days

-21.3%

Last 30 days

-33.9%

Last 90 days

-75.3%

Trailing 12 Months

43.6%

How does BPTH drawdown profile look like?

BPTH Financial Health

Current Ratio

0.43

BPTH Investor Care

Shares Dilution (1Y)

316.13%

Diluted EPS (TTM)

-25.71

Tracking the Latest Insider Buys and Sells of Bio-Path Holdings Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Jan 18, 2019	armistice capital, llc	sold	-	-	-	-
Jan 18, 2019	armistice capital, llc	sold	-171,643	2.6629	-64,457	-

Which funds bought or sold BPTH recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 15, 2024	STATE STREET CORP	sold off	-100	-6,034	-	-%
May 15, 2024	MORGAN STANLEY	sold off	-100	-324	-	-%
May 15, 2024	MORGAN STANLEY	new	-	144	144	-%
May 15, 2024	BANK OF AMERICA CORP /DE/	sold off	-100	-70.00	-	-%
May 15, 2024	BANK OF AMERICA CORP /DE/	new	-	29.00	29.00	-%
May 15, 2024	Tower Research Capital LLC (TRC)	sold off	-100	-4,502	-	-%
May 15, 2024	Tower Research Capital LLC (TRC)	new	-	7,968	7,968	-%
May 15, 2024	Royal Bank of Canada	sold off	-100	-	-	-%
May 15, 2024	CITADEL ADVISORS LLC	sold off	-100	-11,202	-	-%
May 14, 2024	NORTHERN TRUST CORP	sold off	-100	-8,200	-	-%

Are Funds Buying or Selling BPTH?

Are funds buying BPTH calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own BPTH

No. of Funds

Unveiling Bio-Path Holdings Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Apr 03, 2024	intracoastal capital, llc	7.1%	53,700	SC 13G
Feb 02, 2024	hudson bay capital management lp	5.43%	709,616	SC 13G
Feb 14, 2020	sassicaia capital advisers llc	0%	0	SC 13G/A
Feb 14, 2020	anson funds management lp	-	0	SC 13G/A
Feb 10, 2020	cvi investments, inc.	4.0%	152,328	SC 13G/A
Jan 15, 2020	empery asset management, lp	0.14%	5,148	SC 13G/A
Jan 06, 2020	sabby management, llc	0.45%	16,708	SC 13G/A
Dec 02, 2019	cvi investments, inc.	5.5%	202,020	SC 13G
Dec 02, 2019	intracoastal capital, llc	4.3%	163,932	SC 13G
Nov 27, 2019	armistice capital, llc	3.9%	151,515	SC 13G

Recent SEC filings of Bio-Path Holdings Inc

View All Filings

Date Filed	Form Type	Document
May 15, 2024	8-K	Current Report
May 14, 2024	10-Q	Quarterly Report
May 02, 2024	EFFECT	EFFECT
Apr 26, 2024	D	D
Apr 24, 2024	S-1	Initial Public Offering
Apr 19, 2024	424B5	Prospectus Filed
Apr 19, 2024	424B5	Prospectus Filed
Apr 19, 2024	8-K	Current Report
Apr 19, 2024	8-K	Current Report
Apr 18, 2024	8-K	Current Report

Peers (Alternatives to Bio-Path Holdings Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
MRNA	50.9B	6.8B	28.49%	6.05%	-8.53	7.44	-64.45%	-224.75%
HILS	22.5B	216.3K	-0.77%	465779.94%	-2.5K	104.0K	-	-8.13%
ALNY	18.9B	2.0B	2.79%	-21.33%	-56.9	9.43	75.20%	68.82%
BMRN	14.7B	2.5B	-14.30%	-15.94%	71.65	5.96	13.74%	186.89%
INCY	12.8B	3.8B	8.33%	-10.25%	17.2	3.4	8.58%	129.81%
MID-CAP
BBIO	5.6B	107.9M	20.58%	115.45%	-10.31	48.09	54.84%	-28.31%
APLS	5.0B	524.1M	-13.99%	-52.79%	-12.02	9.57	394.93%	39.61%
AXSM	3.6B	251.0M	9.96%	-0.29%	-12.28	14.5	73.58%	-86.73%
ARWR	3.1B	240.7M	9.94%	-31.73%	-6.53	12.77	-1.03%	-213.43%
ACAD	2.4B	813.8M	-14.08%	-36.34%	-1.4K	3	56.43%	98.83%
SMALL-CAP
CPRX	1.9B	411.3M	3.06%	35.16%	29.91	4.73	60.38%	-34.49%
NVAX	1.8B	996.6M	234.45%	75.34%	-4.58	1.83	-26.66%	65.49%
CRBP	480.9M	881.7K	21.10%	351.81%	-14.25	481.06	-77.61%	33.36%
INO	310.9M	4.9M	8.40%	53.85%	-2.49	63.89	-54.97%	48.23%
IBIO	17.1M	2.1M	4.76%	108.64%	-0.74	7.61	-13.45%	69.54%

Bio-Path Holdings Inc News

Latest updates

Bio-Path Holdings Inc Earnings Report: Key Takeaways & Analysis

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-45.1%	2.00	3.00	5.00	7.00	11.00	16.00	19.00	21.00	24.00	27.00	31.00	31.00	33.00	16.00	15.00	18.00	20.00	23.00	18.00	19.00	21.00
Current Assets	-46.2%	2.00	3.00	5.00	6.00	11.00	16.00	18.00	21.00	24.00	26.00	30.00	31.00	33.00	16.00	14.00	17.00	19.00	22.00	17.00	19.00	21.00
Cash Equivalents	-82.1%	0.00	1.00	2.00	3.00	7.00	10.00	14.00	17.00	21.00	24.00	27.00	28.00	31.00	14.00	12.00	14.00	18.00	20.00	15.00	17.00	19.00
Net PPE	-28.9%	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Liabilities	58.1%	4.00	3.00	2.00	1.00	2.00	2.00	2.00	1.00	2.00	1.00	1.00	1.00	2.00	1.00	2.00	2.00	2.00	2.00	2.00	1.00	1.00
Current Liabilities	100.0%	4.00	2.00	1.00	1.00	2.00	2.00	2.00	1.00	2.00	1.00	1.00	1.00	2.00	1.00	1.00	1.00	2.00	1.00	1.00	1.00	1.00
Shareholder's Equity	-695.2%	-2.62	0.00	3.00	5.00	9.00	14.00	16.00	20.00	22.00	25.00	29.00	30.00	31.00	15.00	13.00	16.00	18.00	21.00	16.00	18.00	20.00
Retained Earnings	-2.9%	-110	-107	-104	-101	-96.80	-91.53	-87.56	-84.03	-81.02	-77.66	-73.54	-71.48	-69.67	-67.22	-64.67	-61.70	-59.66	-56.34	-53.95	-51.71	-49.25
Additional Paid-In Capital	0.1%	108	108	107	106	106	106	104	104	103	103	103	101	101	82.00	78.00	78.00	78.00	77.00	70.00	70.00	69.00
Accumulated Depreciation	2.1%	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Shares Outstanding	22.0%	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	14.00	-	-	-	28.00	-	-	-	46.00	-	-	-	18.00	-	-	-	37.00	-

Cashflow (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	42.8%	-1,038	-1,814	-2,781	-3,287	-3,653	-5,000	-3,374	-4,203	-2,526	-2,801	-2,891	-2,653	-1,572	-2,592	-2,353	-3,480	-2,535	-2,245	-1,893	-2,215	-2,008
Share Based Compensation	-5.6%	170	180	178	170	206	209	212	213	217	230	262	189	140	145	143	119	170	162	184	181	157
Cashflow From Investing	-	-	-	-	-	-	-	-	-	-	-23.00	-	-	-	-	-	-	-	-	-	-	-
Cashflow From Financing	-66.1%	174	514	-	-	-	-	-	-	-	-3.00	1,399	-	18,610	4,289	-	-	-	7,289	169	45.00	20,280

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

BPTH Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses
Research and development	$ 2,288	$ 3,989
General and administrative	1,407	1,303
Total operating expenses	3,695	5,292
Net operating loss	(3,695)	(5,292)
Other income
Change in fair value of warrant liability	538
Interest income		19
Total other income	538	19
Net loss	$ (3,157)	$ (5,273)
Net Loss Per Share, Basic
Net loss per share, basic	$ (4.88)	$ (13.25)
Weighted average number of common shares outstanding, basic	647	398
Net Loss Per Share, Diluted
Net loss per share, diluted	$ (4.88)	$ (13.25)
Weighted average number of common shares outstanding, diluted	647	398

BPTH Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEET - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash	$ 188	$ 1,052
Prepaid drug product	632	632
Other current assets	817	1,358
Total current assets	1,637	3,042
Fixed assets
Furniture, fixtures & equipment	1,120	1,120
Less accumulated depreciation	(1,066)	(1,044)
Fixed assets, net	54	76
Right of use operating assets	77	102
Total Assets	1,768	3,220
Current liabilities
Accounts payable	1,746	457
Accrued expenses	1,984	1,346
Current portion of lease liabilities	82	103
Total current liabilities	3,812	1,906
Warrant liability	578	863
Noncurrent lease liabilities	3	10
Total Liabilities	4,393	2,779
Shareholders' equity
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding
Common stock, $.001 par value; 200,000 shares authorized; 754 and 398 shares issued and outstanding, respectively	1	1
Additional paid in capital	108,138	108,047
Accumulated deficit	(110,764)	(107,607)
Total shareholders' equity	(2,625)	441
Total Liabilities & Shareholders' Equity	$ 1,768	$ 3,220

About Bio-Path Holdings Inc

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 (BP1002) for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 (BP1003) for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and BP1001-A for the treatment of solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.

CEO	Mr. Peter H. Nielsen MBA
WEBSITE	biopathholdings.com
INDUSTRY	Biotechnology
EMPLOYEES	10

Bio-Path Holdings Inc Frequently Asked Questions

What is the ticker symbol for Bio-Path Holdings Inc? What does BPTH stand for in stocks?

BPTH is the stock ticker symbol of Bio-Path Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Bio-Path Holdings Inc (BPTH)?

As of Fri May 17 2024, market cap of Bio-Path Holdings Inc is 3.54 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BPTH stock?

You can check BPTH's fair value in chart for subscribers.

What is the fair value of BPTH stock?

You can check BPTH's fair value in chart for subscribers. The fair value of Bio-Path Holdings Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Bio-Path Holdings Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for BPTH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Bio-Path Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether BPTH is over valued or under valued. Whether Bio-Path Holdings Inc is cheap or expensive depends on the assumptions which impact Bio-Path Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BPTH.

What is 5 year return on Bio-Path Holdings Inc's stock?

In the past 10 years, Bio-Path Holdings Inc has provided -0.425 (multiply by 100 for percentage) rate of return.